|

Immunotherapy (Pembrolizumab) Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: Pembrolizumab

Other2 trials

Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
Phase 2
Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma
Phase 2/3

Newport Beach, California1 trial

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

USC Newport Beach

Phase 2/3

Houston, Texas1 trial

Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

The University of Texas Health Science Center at Houston

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.